Kymera Therapeutics Inc at Evercore ISI HealthCONx Virtual Conference Transcript
Awesome. Hi, everyone. This is Maneka Mirchandaney from the Evercore ISI biotech team. Very pleased to be here with Kymera for our next fireside chat. We've got Nello Mainolfi who is President and CEO. Thank you for joining. Really exciting times for Kymera and protein degradation more broadly as well.
Questions & Answers
To start, I guess just give us a quick snapshot of where Kymera is right now.
Yes. Thanks, Maneka, for the invitation. Good morning, everyone.
So yes, exciting time for Kymera. We just announced, I believe, yesterday our third cleared IND of 2021. So it's been a very busy year. So we started the Company with the goal of building completely new drugs using protein degradation and, we believe, has the potential to transform medicines. And I think having now three clinical stage programs, it really makes it feel real.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
